Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis
- PMID: 36028820
- PMCID: PMC9414166
- DOI: 10.1186/s12883-022-02813-z
Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis
Erratum in
-
Correction: Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.BMC Neurol. 2022 Dec 23;22(1):499. doi: 10.1186/s12883-022-03034-0. BMC Neurol. 2022. PMID: 36564763 Free PMC article. No abstract available.
Abstract
Background: Epilepsy is one of the most common neurological disorders worldwide. Yet, its treatment gap is large in some areas and especially in sub-Saharan Africa data on clinical, radiological and semiological characteristics, as well as on treatment of persons with epilepsy (PWE) are still scarce.
Methods: We pooled data from four cross-sectional studies on epilepsy in eastern Africa. Two studies from Malawi and Uganda were community-based; two studies in Tanzania (urban Dar es Salaam and rural Haydom) were hospital-based. Clinical characteristics of PWE were assessed by the same questionnaire. Additionally, data on treatment were collected and computed tomography (CT) scans were performed.
Results: Overall, 1179 PWE were included in our analysis (581 (49.3%) female, median age 22 years (IQR 15-32 years)). Up to 25% of the patients had focal onset seizures. Those showed a higher rate of remarkable CT scan findings, with especially post-ischaemic and neurocysticercosis-associated lesions, compared to PWE with generalized onset seizures (35.1% vs. 20%). The majority of the patients experienced tonic-clonic seizures (70-85%). Only 67-78% of PWE received anti-seizure medication (ASM) treatment in the community-based studies, mostly monotherapy with phenobarbital, phenytoin or carbamazepine. Yet, underdosage was frequent and a large proportion of PWE received alternative non-ASM treatment consisting of herbal treatment (up to 83%) and/or scarification (up to 20%).
Conclusions: Epilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes. PWE suffer from high seizure rates and subsequent injuries, as well as from socio-economic consequences due to insufficient ASM treatment. This pooled analysis illustrates the need for structural programmes for adequate identification, education, assessment and treatment of PWE in sub-Saharan Africa.
Keywords: Epilepsy; Global health; Sub-Saharan Africa; Treatment gap.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Institute for Health Metrics and Evaluation (IHME) University of Washington. Global Burden of Disease Results Tool. https://vizhub.healthdata.org/gbd-results/. Accessed 5 Feb 2020.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous